Tag: FPRX

Finance

Trader’s Recap : Oi SA (NYSE:OIBR), Enphase Energy, Inc. (NASDAQ:ENPH), Pacific Continental Corp. (NASDAQ:PCBK), Red Robin Gourmet Burgers Inc. (NASDAQ:RRGB), Five Prime Therapeutics, Inc. (NASDAQ:FPRX)

Oi SA (NYSE:OIBR) and Telemar Participacoes S.A clarify to their shareholders and the market in general that the announcement of a possible liquidation of the assets of Rio Forte Investments S.A. (“Rio Forte”) as a result of the rejection of the request for controlled management for Rio Forte, which occurred on October 17, shall have no impact on the development of the business combination and … Continue reading Trader’s Recap : Oi SA (NYSE:OIBR), Enphase Energy, Inc. (NASDAQ:ENPH), Pacific Continental Corp. (NASDAQ:PCBK), Red Robin Gourmet Burgers Inc. (NASDAQ:RRGB), Five Prime Therapeutics, Inc. (NASDAQ:FPRX)

Mark DeFrance
Finance

Biotech Volatile Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE), Sorrento Therapeutics (NASDAQ:SRNE), Five Prime Therapeutics (NASDAQ:FPRX), Aratana Therapeutics (NASDAQ:PETX), Pain Therapeutics (NASDAQ:PTIE)

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the presentation of results from a multiple-dose study, conducted by Kyowa Hakko Kirin Pharma, Inc. (KKP), of the investigational anti-FGF23 monoclonal antibody KRN23 (UX023) in adult patients with X-linked hypophosphatemia (XLH). XLH is an inherited metabolic bone disease characterized by short stature, skeletal deformities, … Continue reading Biotech Volatile Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE), Sorrento Therapeutics (NASDAQ:SRNE), Five Prime Therapeutics (NASDAQ:FPRX), Aratana Therapeutics (NASDAQ:PETX), Pain Therapeutics (NASDAQ:PTIE)

Jayne Crisman